AffirmHealth Blog

Jody Lutz


Recent Posts

The Future of Managing Pain: Novel Treatments & Reformulations

Posted by Jody Lutz on Nov 28, 2018 2:26:19 PM

0 Comments

As the opioid misuse and overdose epidemic impacts communities across America and has sweeping global implications, practitioners are looking to the future of pain management and the novel treatment options that may be on the horizon.

Drug trends related to pain management focus on efficacy and patient safety, but with renewed attention to abuse deterrent formulations and side effect profiles. Novel agents as well as reformulations of older, industry standard products are being studied. 

The Food and Drug Administration announced on August 29, 2018 that it intends to withdraw its existing analgesic guidance for developing new pain drugs and will issue new comprehensive guidance in 2019.

READ MORE

MIPS and Improvement Activity Data

Posted by Jody Lutz on Nov 13, 2018 3:28:24 PM

0 Comments

Last week on the AffirmHealth Blog we discussed MIPS and PDMP Usage and promised a follow up on additional Improvement Activities. So this week we look at an Improvement Activities Data overview as well as a handful of activities potentially pertinent to providers prescribing opioids or other controlled substances.

Let’s start at the beginning…

READ MORE

MIPS and PDMP Usage: How they work together.

Posted by Jody Lutz on Oct 30, 2018 12:46:41 PM

0 Comments

MIPS: What is it and what do prescribers need to know? 

READ MORE

Naloxone and Buprenorphine...Access and Accessibility in America

Posted by Jody Lutz on Oct 16, 2018 3:25:41 PM

0 Comments

 

Naloxone is a medication approved by the Food and Drug Administration (FDA) to prevent overdose by opioids it is designed to rapidly reverse opioid overdose. Commercially, it has been available for almost 50 years and several formulations are available, produced by various manufacturers. 

READ MORE

The Opioid Misuse Situation

Posted by Jody Lutz on Oct 9, 2018 9:36:16 AM

0 Comments

Everyday the media is flooded with stories about the toll of opioid addiction in America. New rules and regulations are regularly being introduced on a state and national level as we collectively grapple with how to tackle this epidemic. However, the war on opioids in America is not new. In 2011, the Centers for Disease Control warned that prescription painkiller overdoses had reached what was considered “epidemic levels.”

READ MORE

Sweeping Opioid Legislation Passed By Senate. What you need to know about STOP & OCRA

Posted by Jody Lutz on Sep 25, 2018 11:00:00 AM

0 Comments

On Monday, in a bipartisan move, the Senate overwhelmingly passed legislation aimed at combating the opioid epidemic.

READ MORE
electronic decisions support, Healthcare Databases, controlled substances, opioid legislation, patient risk, clinical practice improvement activities, opioid prescribing, prescriber compliance, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, Clinical Tools, Pain Management, chronic pain, PDMPs, Clinician Perspective, Healthcare

PDMP's: A discussion For and Against a State By State Monitoring Program

Posted by Jody Lutz on Sep 18, 2018 10:00:00 AM

0 Comments

Pharmacy Times reports that, "The first PDMP program was enacted by New York State in 1918 and was used to monitor prescriptions for cocaine, codeine, heroin, morphine, and opium. With this program, pharmacists were required to report copies of prescriptions to the health department within 24 hours."

READ MORE
opioid legislation, regulations, State Opioid Prescibing Guidelines, chronic pain

State Spotlight: Oklahoma is OK for Medical Marijuana

Posted by Jody Lutz on Sep 6, 2018 8:28:00 AM

0 Comments

Oklahoma recently became the 30th state in the US to allow access to medical marijuana. The proposal, which passed by a 57% to 43% margin allows doctors to recommend cannabis for any medical condition they deem medically necessary. This makes Oklahoma's law one of the least restrictive in the country.

READ MORE

 

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

PROTECT YOUR PATIENTS.
PROTECT YOUR PRACTICE.

Drive responsible, compliant opioid prescribing across your organization.

SCHEDULE A CALL

Comments

Categories

see all

Popular Posts